Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05205330
Title A Phase Ib/IIa Study of CR6086 in Combination With Balstilimab in pMMR-MSS Metastatic Colorectal Cancer Patients
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Rottapharm Biotech

colon adenocarcinoma

rectum adenocarcinoma


Balstilimab + CR6086

Age Groups: adult | senior
Covered Countries ITA

Additional content available in CKB BOOST